To support the importance of this Qa-1-epitope-CD8 axis in antigen-specific therapy of MS, recent data have convincingly demonstrated that the dominant role of Qa-1 molecules is presentation of regulatory Qa-1epitopes to the Qa-1-restricted CD8+ Treg cells12, 13, 14, 15. Here, CD8A is linked to myeloid sarcoma.